Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer’s disease pathologies
3
조회
0
다운로드
0
인용
0
참고문헌
초록
Abnormal glial activation promotes neurodegeneration in Alzheimer’s disease (AD), the most common cause of dementia. Stimulation of the cGAS-STING pathway induces microglial dysfunction and sterile inflammation, which exacerbates AD. We showed that inhibiting STING activation can control microglia and ameliorate a wide spectrum of AD symptoms. The cGAS-STING pathway is required for the detection of ectopic DNA and the subsequent immune response. Amyloid-β (Aβ) and tau induce mitochondrial stress, which causes DNA to be released into the cytoplasm of microglia. cGAS and STING are highly expressed in Aβ plaque-associated microglia, and neuronal STING is upregulated in the brains of AD model animals. The presence of the APOE ε4 allele, an AD risk factor, also upregulated both proteins. STING activation was necessary for microglial NLRP3 activation, proinflammatory responses, and type-I-interferon responses. Pharmacological STING inhibition reduced a wide range of AD pathogenic features in AppNL-G-F/hTau double-knock-in mice. An unanticipated transcriptome shift in microglia reduced gliosis and cerebral inflammation. Significant reductions in the Aβ load, tau phosphorylation, and microglial synapse engulfment prevented memory loss. To summarize, our study describes the pathogenic mechanism of STING activation as well as its potential as a therapeutic target in AD.
Abstract
Abnormal glial activation promotes neurodegeneration in Alzheimer’s disease (AD), the most common cause of dementia. Stimulation of the cGAS-STING pathway induces microglial dysfunction and sterile inflammation, which exacerbates AD. We showed that inhibiting STING activation can control microglia and ameliorate a wide spectrum of AD symptoms. The cGAS-STING pathway is required for the detection of ectopic DNA and the subsequent immune response. Amyloid-β (Aβ) and tau induce mitochondrial stress, which causes DNA to be released into the cytoplasm of microglia. cGAS and STING are highly expressed in Aβ plaque-associated microglia, and neuronal STING is upregulated in the brains of AD model animals. The presence of the APOE ε4 allele, an AD risk factor, also upregulated both proteins. STING activation was necessary for microglial NLRP3 activation, proinflammatory responses, and type-I-interferon responses. Pharmacological STING inhibition reduced a wide range of AD pathogenic features in AppNL-G-F/hTau double-knock-in mice. An unanticipated transcriptome shift in microglia reduced gliosis and cerebral inflammation. Significant reductions in the Aβ load, tau phosphorylation, and microglial synapse engulfment prevented memory loss. To summarize, our study describes the pathogenic mechanism of STING activation as well as its potential as a therapeutic target in AD.
참고문헌 (64)
- Leng, F., "Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?", Nat. Rev. Neurol, 17, pp.157~172 (2021)
- Paolicelli, R. C., "Microglia states and nomenclature : A field at its crossroads", Neuron, 110, pp.3458~3483 (2022)
- Baik, S. H., "A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer’s Disease", Cell Metab, 30, pp.493~507 (2019)
- Simon, M., "LINE1 Derepression in Aged Wild-Type and SIRT6-Deficient Mice Drives Inflammation", Cell Metab, 29, pp.871~885 (2019)
- Martins, F., "Nuclear envelope dysfunction and its contribution to the aging process", Aging Cell, 19, pp.e13143~ (2020)
- Lee, M. H., "Somatic APP gene recombination in Alzheimer’s disease and normal neurons", Nature, 563, pp.639~645 (2018)
- Hanna, R., "G-quadruplexes originating from evolutionary conserved L1 elements interfere with neuronal gene expression in Alzheimer’s disease", Nat. Commun, 12, pp.1828~ (2021)
- Guo, C., "Tau Activates Transposable Elements in Alzheimer’s Disease", Cell Rep, 23, pp.2874~2880 (2018)
- Mossmann, D., "Amyloid-beta peptide induces mitochondrial dysfunction by inhibition of preprotein maturation", Cell Metab, 20, pp.662~669 (2014)
- Eimer, W. A., "Alzheimer’s Disease-Associated beta-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection", Neuron, 99, pp.56~63 (2018)
- Readhead, B., "Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus", Neuron, 99, pp.64~82 (2018)
- Andreeva, L., "cGAS senses long and HMGB", TFAM-bound U-turn DNA by forming protein-DNA ladders, 2017, pp.549, 394~398
- Hopfner, K. P., "Molecular mechanisms and cellular functions of cGAS-STING signalling", Nat. Rev. Mol. Cell Biol, 21, pp.501~521 (2020)
- Li, T., "The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer", J. Exp. Med, 215, pp.1287~1299 (2018)
- Mathur, V., "Activation of the STING-Dependent Type I Interferon Response Reduces Microglial Reactivity and Neuroinflammation", Neuron, 96, pp.1290~1302 (2017)
- Standaert, D. G., "Alpha-synuclein-mediated DNA damage, STING activation, and neuroinflammation in Parkinson’s disease", Proc. Natl. Acad. Sci. USA, 119, pp.e2204058119~ (2022)
- Yu, C. H., "TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS", STING in ALS, 2020, pp.183, 636~649
- Sharma, M., "Cyclic GMP-AMP synthase promotes the inflammatory and autophagy responses in Huntington disease", Proc. Natl. Acad. Sci. USA, 117, pp.15989~15999 (2020)
- Xie, X., "Activation of innate immune cGAS-STING pathway contributes to Alzheimer’s pathogenesis in 5×FAD mice", Nat. Aging, 3, pp.202~212 (2023)
- Udeochu, J. C., "Tau activation of microglial cGAS-IFN reduces MEF2C mediated cognitive resilience", Nat. Neurosci, 26, pp.737~750 (2023)
- Saito, T., "Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation", J. Biol. Chem, 294, pp.12754~12765 (2019)
- Chung, S., "Plexin-A4 mediates amyloid-beta-induced tau pathology in Alz heimer’s disease animal model", Prog. Neurobiol, 203, pp.102075~ (2021)
- Lee, J. H., "Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations", Cell, 141, pp.1146~1158 (2010)
- Aarreberg, L. D., "Interleukin-1beta Induces mtDNA Release to Activate Innate Immune Signaling via cGAS-STING", Mol. Cell, 74, pp.801~815 (2019)
- Marsh, S. E., "Dissection of artifactual and confounding glial signatures by single cell sequencing of mouse and human brain", Nat. Neurosci, 25, pp.306~316 (2022)
- Park, J. C., "A logical network-based drug-screening platform for Alzheimer’s disease representing pathological features of human brain organoids", Nat. Commun, 12, pp.280~ (2021)
- Park, J. C., "Multi-Omics-Based Autophagy-Related Untypical Subtypes in Patients with Cerebral Amyloid Pathology", Adv. Sci. (Weinh.), 9, pp.e2201212~ (2022)
- Gulen M. F., "cGAS-STING drives ageing-related inflammation and neurode generation", Nature, 620 (2023)
- Yang, H., "cGAS is essential for cellular senescence", Proc. Natl Acad. Sci. USA, 114, pp.E4612~E4620 (2017)
- Roy, E. R., "Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease", J. Clin. Invest, 130, pp.1912~1930 (2020)
- Li, T., "The neuritic plaque facilitates pathological conversion of tau in an Alzheimer’s disease mouse model", Nat. Commun, 7, pp.12082~ (2016)
- Jin, M., "Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation", Nat. Commun, 12, pp.6565~ (2021)
- Gaidt, M. M., "The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3", Cell, 171, pp.1110~1124 (2017)
- Heneka, M. T., "NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP", PS1 mice, 2013, pp.493, 674~678
- Kim, S. H., "Endolysosomal impairment by binding of amyloid beta or MAPT", Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease, 2023, pp.19, 2318~2337
- Tcw, J., "Cholesterol and matrisome pathways dysregulated in astrocytes and microglia", Cell, 185, pp.2213~2233 (2022)
- Hur, J. Y., "The innate immunity protein IFITM3 modulates gamma-secretase in Alzheimer’s disease", Nature, 586, pp.735~740 (2020)
- Liu, H., "AlzPlatform : an Alzheimer’s disease domain-specific chemogenomics knowledgebase for polypharmacology and target identification research", J. Chem. Inf. Model, 54, pp.1050~1060 (2014)
- Haag, S. M., "Targeting STING with covalent small-molecule inhibitors", Nature, 559, pp.269~273 (2018)
- Keren-Shaul, H., "A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease", Cell, 169, pp.1276~1290 (2017)
- Krasemann, S., "The TREM2-APOE Pathway Drives the Transcriptional Phe notype of Dysfunctional Microglia in Neurodegenerative Diseases", Immunity, 47, pp.566~581 (2017)
- Mathys, H., "Temporal Tracking of Microglia Activation in Neurodegeneration at Single-Cell Resolution", Cell Rep, 21, pp.366~380 (2017)
- Sala Frigerio, C., "The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Abeta Plaques", Cell Rep, 27, pp.1293~1306 (2019)
- Hong, S., "Complement and microglia mediate early synapse loss in Alzhei mer mouse models", Science, 352, pp.712~716 (2016)
- Roy, E. R., "Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid beta plaques", Immunity, 55, pp.879~894 (2022)
- Brelstaff, J., "Living Neurons with Tau Filaments Aberrantly Expose Phosphatidylserine and Are Phagocytosed by Microglia", Cell Rep, 24, pp.1939~1948 (2018)
- McArthur, K., "BAK", BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis, 2018, pp.359, eaao6047~
- De Schepper, S., "Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer’s disease", Nat. Neurosci, 26, pp.406~415 (2023)
- Li, S., "Secreted phosphoprotein 1 slows neurodegeneration and rescues visual function in mouse models of aging and glaucoma", Cell Rep, 41, pp.111880~ (2022)
- Raefski, A. S., "Identification of a cluster of X-linked imprinted genes in mice", Nat. Genet, 37, pp.620~624 (2005)
- Chen, X., "Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy", Nature, 615, pp.668~677 (2023)
- Su W., "CXCR6 orchestrates brain CD8(+) T cell residency and limits mouse Alzheimer’s disease pathology", Nat. Immunol (2023)
- Anastasiou, M., "Endothelial STING controls T cell transmigration in an IFNI dependent manner", JCI Insight, 6, pp.e149346~ (2021)
- Li, W., "cGAS-STING-mediated DNA sensing maintains CD8(+) T cell stemness and promotes antitumor T cell therapy", Sci. Transl. Med, 12, pp.eaay9013~ (2020)
- Willemsen J., "TNF leads to mtDNA release and cGAS", STING-dependent interferon responses that support inflammatory arthritis, 2021, pp.37, 109977~
- Jung, E. S., "Amyloid-beta activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk-AMPK pathway", Aging Cell, 21, pp.e13623~ (2022)
- Swanson, K. V., "A noncanonical function of cGAMP in inflammasome priming and activation", J. Exp. Med, 214, pp.3611~3626 (2017)
- Decout, A., "The cGAS-STING pathway as a therapeutic target in inflammatory diseases", Nat. Rev. Immunol, 21, pp.548~569 (2021)
- Zhou, Y., "Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP", Immunity, 52, pp.357~373 (2020)
- Bode, K., "Dectin-1 Binding to Annexins on Apoptotic Cells Induces Peripheral Immune Tolerance via NADPH Oxidase-2", Cell Rep, 29, pp.4435~4446 (2019)
- Park, J., "Microglial MERTK eliminates phosphatidylserine-displaying inhibi tory post-synapses", EMBO J, 40, pp.e107121~ (2021)
- Welch, G. M., "Neurons burdened by DNA double-strand breaks incite microglia activation through antiviral-like signaling in neurodegeneration", Sci. Adv, 8, pp.eabo4662~ (2022)
- Donnelly, C. R., "STING controls nociception via type I interferon signalling in sensory neurons", Nature, 591, pp.275~280 (2021)
- Spence, J. S., "IFITM3 directly engages and shuttles incoming virus particles to lysosomes", Nat. Chem. Biol, 15, pp.259~268 (2019)
